| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mehdi Namdar, Jan Steffel, Sandra Jetzer, Christian Schmied, David Hürlimann, Giovanni G Camici, Fatih Bayrak, Danilo Ricciardi, Jayakeerthi Y Rao, Carlo de Asmundis, Gian-Battista Chierchia, Andrea Sarkozy, Thomas F Lüscher, Rolf Jenni, Firat Duru, Pedro Brugad. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease. The American journal of cardiology. vol 109. issue 4. 2012-04-04. PMID:22105784. |
value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and fabry disease. |
2012-04-04 |
2023-08-12 |
Not clear |
| Mehdi Namdar, Jan Steffel, Sandra Jetzer, Christian Schmied, David Hürlimann, Giovanni G Camici, Fatih Bayrak, Danilo Ricciardi, Jayakeerthi Y Rao, Carlo de Asmundis, Gian-Battista Chierchia, Andrea Sarkozy, Thomas F Lüscher, Rolf Jenni, Firat Duru, Pedro Brugad. Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease. The American journal of cardiology. vol 109. issue 4. 2012-04-04. PMID:22105784. |
the aim of the present study was to assess the diagnostic value of common electrocardiographic (ecg) parameters to differentiate fabry disease (fd), amyloidosis, and nonobstructive hypertrophic cardiomyopathy (hc) from hypertensive heart disease (hhd) and aortic stenosis (as). |
2012-04-04 |
2023-08-12 |
Not clear |
| Olga Azevedo, Paulo Gaspar, Clara Sá Miranda, Damião Cunha, Rosa Medeiros, António Lourenç. Left ventricular noncompaction in a patient with fabry disease: overdiagnosis, morphological manifestation of fabry disease or two unrelated rare conditions in the same patient? Cardiology. vol 119. issue 3. 2012-02-20. PMID:21952291. |
we report a clinical case of a young female with fabry disease but without left ventricular hypertrophy, which fulfills the diagnostic criteria of left ventricular noncompaction (lvnc). |
2012-02-20 |
2023-08-12 |
Not clear |
| I Rohard, E Schaefer, C Kampmann, M Beck, A Ga. Association between polymorphisms of endothelial nitric oxide synthase gene (NOS3) and left posterior wall thickness (LPWT) of the heart in Fabry disease. Journal of inherited metabolic disease. vol 31 Suppl 2. 2012-01-11. PMID:18941922. |
hypertrophic cardiomyopathy, for example measured by left posterior wall thickness (lpwt) of the heart, represents a major component of fabry disease morbidity in adult patients. |
2012-01-11 |
2023-08-12 |
Not clear |
| Naoki Nakagawa, Hiroki Maruyama, Takayuki Ishihara, Utako Seino, Jun-ichi Kawabe, Fumihiko Takahashi, Motoi Kobayashi, Atsushi Yamauchi, Yukie Sasaki, Naka Sakamoto, Hisanobu Ota, Yasuko Tanabe, Toshiharu Takeuchi, Toshihiro Takenaka, Kenjiro Kikuchi, Naoyuki Haseb. Clinical and genetic investigation of a Japanese family with cardiac fabry disease. Identification of a novel α-galactosidase A missense mutation (G195V). International heart journal. vol 52. issue 5. 2011-12-06. PMID:22008442. |
fabry disease is an x-linked lysosomal storage disorder caused by mutations of the α-galactosidase a gene (gla), and the disease is a relatively prevalent cause of left ventricular hypertrophy mimicking idiopathic hypertrophic cardiomyopathy. |
2011-12-06 |
2023-08-12 |
Not clear |
| Christian Tanislav, Andreas Feustel, Wolfgang Franzen, Oliver Wüsten, Christian Schneider, Frank Reichenberger, Arndt Rolfs, Nicole Siewek. Persistent increase in cardiac troponin I in Fabry disease: a case report. BMC cardiovascular disorders. vol 11. 2011-11-08. PMID:21281467. |
hypertrophic cardiomyopathy is a frequent manifestation in fabry disease (fd) - an x-linked lysosomal storage disorder caused by reduced activity of the enzyme α-galactosidase a. |
2011-11-08 |
2023-08-12 |
Not clear |
| Makoto Yoshimitsu, Koji Higuchi, Masaaki Miyata, Sean Devine, Andre Mattman, Sandra Sirrs, Jeffrey A Medin, Chuwa Tei, Toshihiro Takenak. Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: pitfalls of mutation analyses in patients with low α-galactosidase A activity. Journal of cardiology. vol 57. issue 3. 2011-08-30. PMID:21333496. |
fabry disease is an x-linked lysosomal storage disorder caused by mutations of the α-galactosidase a (gla) gene, and the disease is a relatively prevalent cause of left ventricular hypertrophy followed by conduction abnormalities and arrhythmias. |
2011-08-30 |
2023-08-12 |
Not clear |
| P Bouvagnet, G Millat, R Rousson, G Gilbert, G Derumeau. [Fabry disease among hypertrophic cardiomyopathy of genetic origin]. La Revue de medecine interne. vol 31 Suppl 2. 2011-06-07. PMID:21211671. |
[fabry disease among hypertrophic cardiomyopathy of genetic origin]. |
2011-06-07 |
2023-08-12 |
Not clear |
| P Bouvagnet, G Millat, R Rousson, G Gilbert, G Derumeau. [Fabry disease among hypertrophic cardiomyopathy of genetic origin]. La Revue de medecine interne. vol 31 Suppl 2. 2011-06-07. PMID:21211671. |
the hypertrophic cardiomyopathy of fabry disease is usually unspecific. |
2011-06-07 |
2023-08-12 |
Not clear |
| P Bouvagnet, G Millat, R Rousson, G Gilbert, G Derumeau. [Fabry disease among hypertrophic cardiomyopathy of genetic origin]. La Revue de medecine interne. vol 31 Suppl 2. 2011-06-07. PMID:21211671. |
an italian series of 34 female cases with hypertrophic cardiomyopathy demonstrated that it was feasible to diagnose fabry disease in females by screening for specific lesions in myocardial biopsies. |
2011-06-07 |
2023-08-12 |
Not clear |
| P Bouvagnet, G Millat, R Rousson, G Gilbert, G Derumeau. [Fabry disease among hypertrophic cardiomyopathy of genetic origin]. La Revue de medecine interne. vol 31 Suppl 2. 2011-06-07. PMID:21211671. |
in conclusion, an isolated common hypertrophic cardiomyopathy may be secondary to fabry disease. |
2011-06-07 |
2023-08-12 |
Not clear |
| P Bouvagnet, G Millat, R Rousson, G Gilbert, G Derumeau. [Fabry disease among hypertrophic cardiomyopathy of genetic origin]. La Revue de medecine interne. vol 31 Suppl 2. 2011-06-07. PMID:21211671. |
it is important to think about a putative fabry disease in cases with hypertrophic cardiomyopathy not associated with any obvious cause. |
2011-06-07 |
2023-08-12 |
Not clear |
| A Hagèg. [Cardiac manifestations of Anderson-Fabry disease and efficacy of enzyme replacement therapy]. La Revue de medecine interne. vol 31 Suppl 2. 2011-06-07. PMID:21211672. |
however, in fabry disease, hypertrophy is more often concentric without subaortic obstruction, while search for signs of fabry disease (history of acroparesthesia or anhidrosis, renal dysfunction or stroke) should be systematic. |
2011-06-07 |
2023-08-12 |
human |
| Justina C Wu, Carolyn Y Ho, Hicham Skali, Rekha Abichandani, William R Wilcox, Maryam Banikazemi, Seymour Packman, Katherine Sims, Scott D Solomo. Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity. European heart journal. vol 31. issue 9. 2011-04-29. PMID:20061327. |
cardiovascular manifestations of fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase a activity. |
2011-04-29 |
2023-08-12 |
Not clear |
| Markus Niemann, Dan Liu, Kai Hu, Sebastian Herrmann, Frank Breunig, Jörg Strotmann, Stefan Störk, Wolfram Voelker, Georg Ertl, Christoph Wanner, Frank Weideman. Prominent papillary muscles in Fabry disease: a diagnostic marker? Ultrasound in medicine & biology. vol 37. issue 1. 2011-04-19. PMID:21084151. |
combining these two parameters yields a sensitivity of 75% and specificity of 86% for diagnosing fabry disease with lv hypertrophy. |
2011-04-19 |
2023-08-12 |
Not clear |
| Koji Fukuzawa, Akihiro Yoshida, Tetsuari Onishi, Atsushi Suzuki, Gaku Kanda, Kaoru Takami, Hiroyuki Kumagai, Satoko Torii, Mitsuru Takami, Yuko Fukuda, Hiroya Kawai, Ken-ichi Hirat. Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia. Journal of cardiology. vol 54. issue 1. 2011-03-10. PMID:19632534. |
dilated phase of hypertrophic cardiomyopathy caused by fabry disease with atrial flutter and ventricular tachycardia. |
2011-03-10 |
2023-08-12 |
Not clear |
| Koji Fukuzawa, Akihiro Yoshida, Tetsuari Onishi, Atsushi Suzuki, Gaku Kanda, Kaoru Takami, Hiroyuki Kumagai, Satoko Torii, Mitsuru Takami, Yuko Fukuda, Hiroya Kawai, Ken-ichi Hirat. Dilated phase of hypertrophic cardiomyopathy caused by Fabry disease with atrial flutter and ventricular tachycardia. Journal of cardiology. vol 54. issue 1. 2011-03-10. PMID:19632534. |
we describe a case of a 60-year-old male with dilated phase of hypertrophic cardiomyopathy caused by fabry disease. |
2011-03-10 |
2023-08-12 |
Not clear |
| Albert A Hagège, Eric Caudron, Thibaud Damy, Raymond Roudaut, Alain Millaire, Caroline Etchecopar-Chevreuil, Thi-Chien Tran, Firas Jabbour, Catherine Boucly, Patrice Prognon, Philippe Charron, Dominique P Germai. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study. Heart (British Cardiac Society). vol 97. issue 2. 2011-03-09. PMID:21062768. |
screening patients with hypertrophic cardiomyopathy for fabry disease using a filter-paper test: the focus study. |
2011-03-09 |
2023-08-12 |
Not clear |
| Albert A Hagège, Eric Caudron, Thibaud Damy, Raymond Roudaut, Alain Millaire, Caroline Etchecopar-Chevreuil, Thi-Chien Tran, Firas Jabbour, Catherine Boucly, Patrice Prognon, Philippe Charron, Dominique P Germai. Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS study. Heart (British Cardiac Society). vol 97. issue 2. 2011-03-09. PMID:21062768. |
patients with fabry disease (fd) show left ventricular hypertrophy (lvh) mimicking hypertrophic cardiomyopathy (hcm) of sarcomeric origin and might benefit, if detected early, from specific enzyme replacement therapy. |
2011-03-09 |
2023-08-12 |
Not clear |
| Tomas Palecek, Jan Bultas, Milan Hajek, Debora Karetova, Petr Kuchynka, Josef Kautzner, Milan Elleder, Ales Linhar. Association between cardiac energy metabolism and gain of left ventricular mass in Fabry disease. International journal of cardiology. vol 144. issue 2. 2011-02-01. PMID:19344961. |
left ventricular (lv) hypertrophy is the hallmark of cardiac involvement in fabry disease (fd). |
2011-02-01 |
2023-08-12 |
human |